Clinical Trial Update: Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women [Phase 3]

View source ↗

Summary

Phase 3 trial results posted evaluating MSJ-0011 for inducing ovulation in anovulatory or oligo-ovulatory Japanese women; the study assessed efficacy and safety…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anovulation
• Hypothalamic-pituitary Dysfunction
• Oligo-ovulation
• Polycystic Ovary Syndrome

Drugs mentioned

• MSJ-0011

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Anovulation, Oligo-ovulation | Phase 3 | Status: COMPLETED | Results posted: 2016-01-07